Guest guest Posted November 21, 2004 Report Share Posted November 21, 2004 The following was taken from the AAAI website. Researchers included staff from National Jewish in Denver. National Jewish is currently involved in clinical trials of cleaning solutions that are intended to denature mycotoxins in mold exposed materials. However, National Jewish has made recent statements in the press that they do not acknowledge any serious health effects associated with mold exposures. Lee > Molds Previous attempts at producing mold extracts with reliable allergenic potency have been unsuccessful. Despite this limitation, the committee has identified the following list of Deuteromycetes as the most clinically relevant molds to be considered for inclusion (if clinically appropriate) in allergen immunotherapy vaccines. The committee vigorously supports ongoing efforts to characterize mold allergens that will result in standardized commercial mold extracts. 29. Alternaria alternata 30. Cladosporium herbarum 31. Cladosporium cladosporioides 32. Penicillium chrysogenum 33. Aspergillus fumigatus 34. Epicoccum nigrum 35. Helminthosporium solani * standardized allergen extracts are commercially available References 1. Schwietz LA et al. Cross reactivity among conifer pollens Ann Allergy Asthma Immunol 2000 84;87-91. 2. Weber R, HS. Pollen allergens and their interrelationships. Clin Rev Allergy 1985; 3:291-318. 3. Bernstein IL. In vitro cross-allergenicity of major aeroallergenic pollens by the radioallergosorbent technique 1974; 57:141-52. 4. Aalberse RC. Structural biology of allergens. JACI 2000; 106: 228-38. 5. WH, Imber WE. Allergy epidemiology in St. Louis, Missouri area. Ann Allergy 1975;35:113-9. 6. WH, Vinay P, Zenger VE. Airborne and allergenic pollen of North America. Ed. s Hopkin University Press 1983. 7. 1999 Pollen and Spore reports. American Academy of Allergy Asthma and Immunology 2000. 8. Garner L. Cross reactivity: fact or fiction. 9. Bauer L et al. IgE cross reactivity between birch pollen, mugwort and celery. Clin Exp Allergy 1996;26:1161-1170. 10. Niederberger V. Recombinant birch pollen allergens (rBet v 1 and rBet v2) contain most of the IgE epitopes present in burch, alder, hornbeam, hazel and oak pollen. JACI 1998;102:579-91. 11. Katial et al. Mugwort and sage (Artemisia) pollen cross reactivity. Ann Allergy Asthma Immunol 1997;79:340-46. Copyright © 1998 - 2004. American Academy of Allergy Asthma and Immunology Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.